GLP1R and cholangiocarcinoma: Although exendin-4 (exenatide), a GLP-1R agonist, could increase chemosensitivity and inhibit the proliferation of CCA cells24, the GLP-1R itself promoted epithelial-mesenchymal transformation (EMT), resulting in enhanced migration and invasion of CCA25.